Nectar Lifesciences Buyback 2025 Record Date, Price & Ratio Details

Nectar Lifesciences Buyback 2025 details: The Nectar Lifesciences Buyback open date is 2025. Nectar Lifesciences Buyback record date December 24, 2025. The investor should buy the Nectar Lifesciences Buyback shares before the record date to get eligibility for the buyback.

Table of Contents

Nectar Lifesciences Buyback of ₹81.00 crores approved by the board of directors at the meeting was held on December 3, 2025. Nectar Lifesciences Buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ₹1 each equity share at a price of ₹27 per Equity Share and for an aggregate amount not exceeding ₹81.00 crores from the shareholders. Check out Nectar Lifesciences Buyback 2025 details below:


Nectar Lifesciences Buyback About us

To be updated soon

Nectar Lifesciences Buyback History

  • N/A

Nectar Lifesciences Buyback 2025 Dates

Buyback Meeting Date:December 3, 2025
Buyback Announcement Date:December 5, 2025
Buyback Record Date:December 24, 2025
Last Date to Buy Shares:December 23, 2025
Buyback Open Date:2025
Buyback Close Date:2025
Finalization of Buyback Acceptance:2025

Nectar Lifesciences Buyback 2025 Offer Details

Nectar Lifesciences Buyback of 3,00,00,000 equity shares at a price of ₹27 per equity share. The buyback offers not to exceed ₹81.00 crores of the total buyback offer size.

Offer Amount:₹81.00 Crores
Number of Shares:3,00,00,000 Equity Shares
Face Value:₹1 per equity share
Buyback Price:₹27 per equity share
Listing:BSE, NSE
Buyback Type:Tender Offer
Letter of Offer:Click Here

Nectar Lifesciences Buyback 2025 Acceptance Ratio

The investor should buy around 7,407 shares at a current market price of ₹20.97 (as of date). The calculation will be ₹2,00,000 / ₹27 buyback price = 7,407 shares.

Acceptance RatioInvestmentShares BuybackProfit
33%₹[.][.]₹[.]
50%₹[.][.]₹[.]
75%₹[.][.]₹[.]
100%₹[.][.]₹[.]

Nectar Lifesciences Financial Report

₹ in Crores
YearRevenueExpensePAT
2023₹1,566.85₹1,607.54₹22.46
2024₹1,698.66₹1,680.39₹5.00
2025₹1,674.97₹1,836.50₹113.68

How to Participate in Nectar Lifesciences Buyback 2025

The investors are eligible for the buyback scheme who have Nectar Lifesciences Buyback shares in their Demat Account as the Record Date. Eligible Share Holders can participate in the Nectar Lifesciences Buyback 2025 scheme as per the opening form by selling their shares. The payment will be given as per the Nectar Lifesciences Buyback accepted shares by the company under the Nectar Lifesciences Buyback scheme.

Nectar Lifesciences Buyback 2025 Registrar

Kfin Technologies Ltd.
KFintech, Tower-B, Plot No 31 & 32,
Financial District, Nanakramguda, Gachibowli,
Hyderabad, Telangana India – 500 032.
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://ipostatus.kfintech.com/

Nectar Lifesciences Buyback 2025 Lead Managers

  • Master Capital Services Ltd.

Nectar Lifesciences Company Address

Nectar Lifesciences Limited
Shop No. 5, SL Enclave,
Behind Sohi HP Gas Agency,
Barwala Road,
Dera Bassi, Punjab, 140507
Phone: +91-0172-5078200
Email: [email protected]
Website: https://www.neclife.com/

Nectar Lifesciences Buyback 2025 FAQs


When is Nectar Lifesciences Buyback 2025 Record Date?

Nectar Lifesciences Buyback 2025 record date is December 24, 2025.

When is Nectar Lifesciences Buyback 2025 Open Date?

Nectar Lifesciences Buyback 2025 open date is 2025.

What is Nectar Lifesciences Buyback 2025 Price?

The company has fixed the price at ₹27 per share.

How to apply for Nectar Lifesciences Buyback 2025?

As per the record date you need to have Nectar Lifesciences Buyback shares in your Demat Account. You can participate in buyback after having the stock in your Account.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *